South Korea’s fast-track drug approval process, managed by the Ministry of Food and Drug Safety (MFDS), accelerates the review of drugs addressing serious, life-threatening, or unmet medical needs. Eligible drugs receive priority evaluation, reducing approval timelines while maintaining safety and efficacy standards, to ensure faster access for patients in need.